Precision Medicine for Severe Craniofacial Pain.

NALGOOVA THERAPEUTICS is developing a targeted, minimally invasive interventional solution for severe craniofacial pain conditions, including trigeminal neuralgia and refractory facial pain syndromes. Built around a patient-centric philosophy, our approach focuses on anatomical precision and individualized procedural targeting to address localized pain pathways. Positioned between long-term pharmacological management and highly invasive neurosurgical intervention, the platform is being advanced with a strong emphasis on clinical reproducibility, workflow integration within specialized pain centers, and structured evidence generation.

We are currently engaging with clinical partners, healthcare professionals, and strategic investors committed to advancing precision-based solutions for patients living with severe facial pain. Get in touch.

Technology under development. Not yet approved for clinical use. Information provided on this website does not constitute medical advice.